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Abstract 
The Clinical Nurse Leader project took place at a 106-bed community hospital in 
Washington. The microsystem has five operating rooms where they provide outpatient, 
and inpatient surgical procedures. The goal of this project is to reduce and sustain a near 
zero number of surgical site infections by implementing the use of a no rinse 2% CHG 
cloth in the surgical patient. The specific aim of the project is to reduce the rate of SSIs 
by 80% by December 31st, 2015. Due to a lack of a standardized care, specifically 
designed for the prevention of SSIs, the microsystem is experiencing a higher rate of SSIs 
than desired. Methods utilized in this project were data of the current SSI rates for fiscal 
year 2015, and thorough unit assessment. The data revealed that the microsystem had 
incurred a total of 12 SSIs, which cost a total of $249,420 to treat. The cost of 
implementation of the 2% CHG cloth annually is $12,168. The pre-intervention results 
found variations in preoperative skin preparation, and a lack of compliance. Interventions 
included the standardization of preoperative skin process, developing education for staff 
and patients, and determining how product would be dispersed to patients. The specific 
aim goals will not be actualized until data analysis is completed on December 31st, 2015.  
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Clinical Leadership Theme 
 This project centers on the CNL curriculum element of Nursing 
Leadership. The CNL function is that of Advocate.  I will be disseminating current 
evidence based practices to prevent surgical site infections (SSIs) in Perioperative 
Services. This project requires collaboration and communication with the 
interdisciplinary team regarding the improvement of patient safety and quality. 
Teamwork and collaboration are essential components for advocating change in any 
microsystem. As the CNL, I will develop and sustain an environment that is conducive to 
changing current practices. This project is evidenced based, and constructed on best care 
outcomes. The clinical and economic implications of surgical site infections are 
significant.  
Statement of the Problem 
 Infection control is a critical component of patient safety. Nosocomial, or 
hospital-acquired infections are today by far the most common complication affecting 
hospitalized patients. Surgical-site infections are second in frequency (about 20 percent) 
and third in cost (Burke, 2003). According to the Centers for Disease Control (2015), “In 
2010, an estimated 16 million operative procedures were performed in acute care 
hospitals in the United States. A recent prevalence study found that SSIs were the most 
common healthcare-associated infection, accounting for 31% of all HAIs among 
hospitalized patients.” With advancements in health care practices (infection control 
practices, surgical technique, antimicrobial prophylaxis), SSIs are still a significant cause 
of morbidity, mortality, costly, and need for further treatment.  
Project Overview 
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The goal of this project is to reduce and sustain a near zero number of surgical site 
infections by implementing the use of a no rinse 2% CHG cloth in the surgical patient. 
Surgical patients will cleanse with CHG cloth baths prior to the day of surgery and the 
day of surgery to reduce superficial soil, and transient soil to decrease the risk of wound 
contamination. It is imperative to make patient safety and quality of care strategic 
priorities. 
This project will consist of interdisciplinary collaboration, developing staff, and 
patient education, and data analysis pre and post implementation. Other focuses will be 
on drafting and finalizing standardized processes and drafting a sustainability plan. 
Strategic planning on how CHG wipes will be delivered to inpatients as well as 
outpatients who bypass the preadmission visit.  
To lessen or negate potential barriers as the CNL, I will need to develop a 
standardized order set for pre-operative skin care, develop a strategy for distribution of 
the skin antiseptic at a low cost to ensure availability and use (inpatient and outpatient), 
and educating staff and patients on how to appropriately apply the skin antiseptic prior to 
the day of surgery, and day of surgery.  
The specific aim statement for the project is: The goal is to reduce SSIs by 80% 
by Dec 31st, 2015. This aim correlates with the global aim of improving patient safety, 
and quality by reducing SSIs in the surgical patient population. Each and every patient 
deserves and should be provided with the same care that encompasses and focuses on 
patient safety, and reducing risk. 
Rationale 
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 The data analysis from the IP report for 2015 showed that the microsystem is 
experiencing surgical site infections at a higher rate than desired as a result of not having 
a standard of care designed specifically for the prevention of SSIs (Appendix A). The 
data collected in regards to SSIs in the microsystem show that in the fiscal year of 2015 
that the microsystem incurred a total of 12 SSIs, and spending $249,420 dollars on SSI 
treatment. By implementing a 2% CHG cloth for preoperative skin cleansing could 
possibly reduce the rate of SSIs when bundled with the Surgical Care Improvement 
Project measures.  
The cost evaluation for the microsystem shows in detail the cost savings that the 
organization could possibly achieve. A significant organism average cost (SSI) costs $20, 
785 depending on the severity, where costs could possibly rise depending on nature of 
infection, and patient comorbidities. Estimated surgical procedures performed per year in 
the microsystem are 1,300. The overall SSI in the microsystem for the fiscal year of 2015 
is 12. Estimated HAI Cost for Select Infections for Fiscal year 2015:$249,420. The costs 
of the CHG wipes are: $5.85/pack with 2 packs per patient. $11.70 per patient for 
preoperative bathing. Cost of 2% CHG Cloth Annually is $12,168.00 (Appendix B). As 
we can see from the cost evaluation the cost of implementing preoperative bathing 
outweighs the cost of a preventable SSI. The clinical and economic implications of 
surgical site infections are significant. By preventing and lowering the incidence of SSIs 
will result in less readmissions, decreased length of stay, reoperation, and decreases costs 
associated with SSIs (Appendix C). 
 Also a root cause analysis was performed prior to implementation, which 
identified causal factors that could trigger variation in performance (Appendix D). 
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Several causes for the unsuccessful implementation were noted. The RCA sets an 
illustration of what barriers might be foreseen prior to implementation, and creating an 
action plan to deter obstacles.  
Methodology 
 The purpose of this project is to reduce surgical site infections by 80% three 
months after the implementation of preoperative surgical skin antisepsis protocol. The 
interdisciplinary team must take into account prolonged length of stay, cost of treating the 
infection, longer antibiotic regimens, extra tests, and pain and suffering for patient. 
Todays healthcare is focused on “pay for performance”, which emphasizes eliminating 
preventable errors which includes most SSIs. 
Phase one of the project comprised of an extensive systematic literature review, 
review of existing preoperative skin prophylaxis guidelines, best care guidelines, and 
current practices, and current microsystem data on SSIs. Steps that have been taken to 
date for implementing preoperative skin care are: selecting CHG cloth product, 
establishing baseline data, developing a communication plan, providing current 
information that can be used in the regional newsletter on the upcoming change in 
policy/procedure.  
Phase two consists of: working on developing education for patient and the 
interdisciplinary team, working on printed instructions for proper bathing with CHG 
cloths. Education not only needs to be focused in the Perioperative unit but also in the 
inpatient unit, and emergency room. There are many patients who are inpatients or in the 
ER who are scheduled for surgery, and are not receiving any preoperative surgical skin 
care prior to surgery. As the CNL, I will also need to draft and communicate the 
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standardized process to the Perioperative Leadership team, and identify how progress will 
be communicated to the interdisciplinary team. 
The change theory that I am applying to this project would be Lewin’s change 
model. During the first phase known as unfreezing, I will need to address the detrimental 
events of SSIs, anticipate resistance from the interdisciplinary team, communicating the 
plan for change in an open, and structured manner to increase communication, and 
participation. Communication in this stage is critical so that the interdisciplinary team can 
be informed about the future change. Many people resist change, in the “unfreezing” 
stage. I will inform staff of the impact of SSIs and how it hinders patients, staff, and 
organization. The second phase changing. This would be the implementation of CHG 
wipes for preoperative bathing. I know that during this phase I will be getting some 
resistance from staff. The stage of “changing” must be carefully, and thoughtfully 
prepared for success. By preparing staff and educating the staff on the risks of 
noncompliance (time, expense, patient satisfaction, and payment) I can better prepare 
staff for the needed change. Must have support from risk management, infection control, 
and Perioperative Leadership team.  The final stage of Lewin’s change theory, 
“refreezing.” Reinforcing the new state of change. I find this to be the most crucial stage 
for change. The interdisciplinary team could possibly revert back to former behavior 
unless changes are not reinforced. This is a perfect time for reassessing staff’s feelings on 
change. It is crucial as the CNL to provide an environment that is positive, and 
encouraging. 
Actions to be taken once the project is implemented are random retrospective 
chart audits, and measuring compliance from staff. Compliance will be monitored by 
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preoperative skin cleansing audits. Accurate auditing is crucial in addressing compliance. 
If compliance is a barrier after implementation audits can help address those providers 
who may need extra education/support. Leadership support is essential for 
implementation, maintaining, and sustaining a preoperative skin antisepsis program. 
Data results that will be collected to check if the project is effective will be 
monthly data on current SSIs rates in the microsystem. Running a preoperative skin care 
report through the EMR will collect this data. After three months post implementation 
data will be compared from previous months to see if the preoperative skin cleanse is 
effective. Predictions I see are better surveillance and feedback of SSI data to surgeons.   
Data Source/Literature Review 
The focus of my project will be based on retrospective chart audits, comparing 
baseline information on SSI rates in the microsystem and post implementation data. Also 
unit assessment will be assessed to see what current practices are within the microsystem. 
Current processes with preoperative skin cleansing will be assessed, and evaluated as 
well. Currently, there is no policy in regards to preoperative skin preparation in the 
microsystem. Patients that are seen in physician offices prior to surgery are not receiving 
any type of preoperative skin preparation, as well as patients on the unit, and the 
emergency room who are scheduled for surgery. The amount of patients who are not 
receiving a presurgical skin prep is alarming. The transient soil, and superficial soil on 
the patients skin can cause an increased risk in post operative SSI.   
The PICO statement that was used to assess the appropriate evidence based 
practice guideline was: “In surgical patients who receive preoperative CHG (P) does 
CHG bathing (I) compared to non-CHG bathing (C) decrease Surgical Site Infections 
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(O)?” The PICO statement resulted in several literature results. The PICO statement 
generated 117 results on CINAHL. I then refined the timeline from 2010-2015, which 
resulted in 70 results. I then went to the Cochrane Database of Systemic Reviews and 
entered the same PICO statement with the timeline from 2010-2014, which resulted in 34 
literature results. The PICO statement was useful in attaining information that was 
specific to my PICO statement. 
There were several articles that were evidence-based. Evidence based practice 
(EBP) utilizes current knowledge into care decisions that improve care processes, and 
patient outcomes. By implementing, and utilizing EBP can help support the need, and 
importance for this project. There are still many people (surgeons, and nurses) who are 
skeptical of the importance of preoperative skin preparation prior to surgery. There needs 
to be added stress, and education on the impact of SSI’s on both patient and 
interdisciplinary team.  
Recent evidence based- scientific and clinical studies support two types of CHG 
application (2% CHG coated cloth or 4% CHG soap) using a standardized, timed process 
prior to hospitalization admission as an effective approach for reducing the risk of 
postoperative surgical site infections (Edmiston, Okoli, Graham, Sinski, & Seabrook, 
2010, p.512). The microsystem has chosen the 2% coated CHG wipes for the presurgical 
skin care regimen. Each patient will receive 2 bathes one the day prior to surgery, and 
one the day of surgery in the short stay unit.  
In 2010, the New England Journal of Medicine published an article that presented 
evidence to support the use of three components shown to decrease SSIs. These 
components were: preoperative bathing or showering with chlorhexidine soap, 
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preoperative skin antisepsis with an alcohol-containing agent, and screening patients for 
Staph aureus and intranasal Mupirocin decolonization of S. Aureus carriers (New 
England Journal of Medicine, 2010). Also the study showed that in a randomized study 
that the application of chlorhexidine-alcohol minimized the risk of SSIs by 41% as 
compared with the most widespread practices in the United States of using aqueous 
povidine-iodine (NEJM, 2010). 
Karki, Cheng (2012), conducted a systematic review of the impact of no-rinse 
skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated 
infections and colonization with multi-resistant organisms. The study wanted to measure 
the impact of skin cleansing with CHG impregnated or saturated washcloths in inhibiting 
healthcare-associated infections and colonization. The results from the study suggest that 
the use of a no-rinse CHG wipes significantly reduces the risk of CLABSI, SSI, and 
colonization with VRE and MRSA but not infection. Studies have shown that the use of a 
no-rinse 2% CHG impregnated washcloth has a higher amount of CHG residual left on 
the skin than that of the 4% CHG solution. The microsystem has chosen the 2% no rinse 
CHG wipes for preoperative skin preparation. Currently, the microsystem is the pilot for 
the trialing of preoperative skin preparation prior to the target implementation, which will 
be applied regionally. 
Lee, Agarwal, Lee, Fishman, & Umscheid (2010), compared the use of 
chlorhexidine with use of iodine for preoperative skin antisepsis in its effectiveness in 
preventing surgical site infections. The results from the study revealed that chlorhexidine 
antisepsis was associated with significantly lower rates of SSIs than with iodine. The cost 
benefit model in this study showed that switching from iodine to CHG resulted in a net 
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cost savings of $16-$26 dollars per surgical case which resulted in a savings of $349,904-
568,594 per year for the hospital (Lee, Agarwal, Lee, Fishman, & Umscheid, 2010). The 
cost benefit model in this study shows promise with the use of a no rinse 2% CHG as a 
preoperative skin antisepsis in significantly lowering SSIs in the microsystem. Also the 
study shows that the implementation of a preoperative skin prep resulted in massive 
savings to the organization from the prevention of SSI care.  
Pyrek, K (2015), the author addressed the challenges to the implementation of 
CHG bathing interventions. The author also emphasized the significance of compliance 
that CHG bathing is being properly performed. There were many variations that were 
found after implementation. This article was helpful in determining and understanding 
possible barriers to compliance. Takeaways from this article that will be applied to the 
microsystem project were the importance of standardization and compliance with the no 
rinse CHG wipes, and that CHG bathing is being performed properly. Another barrier 
that stood out that I can see as an issue is convincing the interdisciplinary team that this is 
the appropriate intervention. It is essential to get interdisciplinary buy-in and address 
competencies in providing accurate and through education about CHG’s 
contraindications, and benefits. 
 Zywiel, M., Daley, J., Delanois, R., Naziri, Q., Johnson, A., & Mont, M. (2011), 
the author’s in this study wanted to evaluate the incidence of deep SSIs in knee 
arthroplasty patients who used an advanced preoperative skin preparation compared to 
patients who only received a standard perioperative preparation. An additional purpose of 
the study was to compare the infection rates between the two groups. Group one was 
given 2% chlorhexidine-impregnated cloths for their advanced pre-operative skin 
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preparation, while group two received no pre-operative skin preparation. Zyweil et al. 
(2011) concluded “Results showed a considerably lower incidence of SSIs in patients 
who complied with the advanced skin preparation compared to those patients who did 
not. There were no SSIs among the 136 patients who used the advanced pre-operative 
skin protocol compared to 21 infections in 711 patients who used the in-hospital 
preparation only” (p. 1003).  
The research findings of this study are useful and applicable implications for 
healthcare providers to reduce surgical site infections as well as improving the quality of 
patient care by reducing preventable SSIs in the postoperative period. The findings also 
form a basis for a change of practice for pre surgical patients. Lowering surgical site 
infections will result in less readmission or prolonged length of stay, reoperation, and 
sepsis or infection.    
Timeline 
 The project was initiated March 25th, 2015. Current processes that have been 
completed to date are: drafting charter, determining which product will be used, and 
supplied, establishing baseline SSI data, and providing current information that can be 
used for the regional newsletter.  
 Project initiatives that are in process are: developing education for physicians, 
staff, and patient as well as targeting the inpatient interdisciplinary team (Appendix E). 
Target implementation date for the outpatient unit is set for September 1st, 2015, and the 
inpatient target implementation date is set for December 1st, 2015.  
Expected Results 
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 Outcomes that are expected from this project are a reduction in surgical site 
infections within the microsystem. The desired goal will be met if there is a reduction of 
SSIs by 80% three months following implementation. Return on investment cost will 
produce substantial cost savings (skin antisepsis product cost, decreased number of SSIs 
resulting in significant cost savings). Number of patient readmitted for SSI decreased by 
75%, and interdisciplinary compliance in pre-op skin antisepsis. Also I foresee better 
surveillance with patients and SSI tracking. There needs to be a multimodal approach 
involving active post discharge surveillance, as well as measures at every step of the 
healthcare delivery process, ranging from the Short Stay Unit to Post Discharge.  
Nursing Relevance 
 Reducing SSIs in the preoperative patient will bring a significant contribution to 
nursing profession since reducing risks and patient safety are key quality, and safety 
issues. Due to increasing prevalence, extent of injury, and rising healthcare costs, related 
to SSIs, SSI prophylaxis has become a national priority. Nurses in all settings need to be 
able to detect postoperative wound infections. Perioperative nurses play a key role in 
decreasing SSI risk postoperatively, however due to the variety of settings patients are 
seen in, it is imperative that all nurses have the ability and training to assess for wound 
infection.  
Each and every patient should be provided the same care in regards to safety, 
quality, and the prevention of surgical site infections. It is essential that we reduce SSIs 
so that we can provide high quality, cost effective care to all of our patients. It is essential 
to make patient safety and quality of care strategic priorities in order for any care 
improvement project to be successful.  
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Conclusion 
The specific aim statement for the project is: The goal is to reduce SSIs by 80% 
by Dec 31st, 2015. This aim correlates with the global aim of improving patient safety, 
and quality by reducing SSIs in the surgical patient population. Each and every patient 
deserves and should be provided with the same care that encompasses and focuses on 
patient safety, and reducing risk. 
The microsystem is a 106-bed community hospital in Washington. The 
microsystem has five operating rooms where they provide outpatient, and inpatient 
surgical procedures. A majority of cases consist of: general, orthopedics, plastics, 
podiatry, gynecology, urology, and robotic surgical procedures. The patients in the 
microsystem are all surgical patients.  
Modifications to the project included estimating SSIs that adjusts for risk factors 
associated with infection for different care settings, and procedures. Also developing a 
plan with surrounding outpatient clinics to develop a communication tactic for tracking 
SSIs, and reporting back to the hospital.   
Published material that will be used for teaching aids for both staff, and patient is 
a preoperative skin preparation anatomical diagram, which has graphical instructions for 
the use of preoperative skin wipes. Also included will be a preoperative skin checklist 
that the patient will fill out and bring on the day of surgery. Patients will remove adhesive 
sticker from the package and affix the sticker to the protocol instruction sheet, to record 
and confirm compliance. For inpatients/emergency surgical procedures the nurse will 
instruct the patient on the proper use and application of preoperative skin preparation. 
Depending on patient limitations the nurse may assist the patient in skin disinfection. The 
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nurse will then document and report to the Operating Room nurse that preoperative skin 
preparation was appropriately applied, and completed.  
The  Clinical Nurse Leader project initiated numerous strategies for the 
microsystem to incorporate in support of the implementation of the preoperative skin 
preparation policy. A specific preoperative skin report was created to retrieve data on the 
completion of skin preparation in the EMR to ensure that all elements of the protocol 
were completed. The microsystem project also established and created a reliable, 
standardized system to obtain complete preoperative skin preparation, a consistent 
process to communicate completed preoperative skin preparation, and developed a 
patient-centered approach to education. Lessons learned from this project are: leadership 
support, surgeon and nurse champions are unquestionably vital for the successful 
implementation, and sustainability of this policy.  
The specific aim goals will not be actualized until data is available December 31st, 
2015. Then the microsystem will be able to compare “before and after” data to see if they 
have reached it’s goal of reducing SSIs by 80% 3 months post implementation. 
Compliance measures will be obtained by random retrospective chart audits, and incident 
reports for those who are non compliant.  Audits will occur randomly, and will be an 
ongoing process. Accurate auditing is crucial in addressing compliance. If compliance is 
a barrier after implementation audits can help address those providers and staff who may 
need extra education and support. Monthly reports on compliance will be available for 
staff to see. Trends will be followed in quarterly reports, and findings will be 
communicated to Perioperative Leadership team, surgeons who have a trend of SSI 
complications, and the interdisciplinary staff. As the CNL, it is critical that education, 
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and compliance are adhered to. After data is available following the post implementation 
period recommendations will be made based on the microsystems data. Improvement 
takes place over time. Determining if improvement has actually occurred and if the 
implementation is successful will require observing of patterns over time.  
The implementation of a preoperative skin preparation with 2% CHG no rinse 
cloth can aid in reducing the incidence of an avoidable adverse event and is a crucial 
component of improving patient safety . Nosocomial, or hospital-acquired infections are 
today by far the most common complication affecting hospitalized patients. By educating 
and implementing the preoperative skin preparation policy we can increase patient 
satisfaction by providing a culture of safety, and quality of care based on evidence based 
practices. The findings from this project are useful and applicable for healthcare 
providers to reduce surgical site infections as well as improving the quality of patient care 
by reducing preventable SSIs in the postoperative period. The findings also develop a 
basis for a change of practice for pre-surgical patients. Reducing surgical site infections 
will result in less readmissions, decreased length of stay, reoperation, and decreased costs 
associated with SSI care.  
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Appendix A 
Denominators 
  
July Aug Se
pt 
Oc
t 
Nov Dec Jan Feb Mar Ap
ril 
M
ay 
Ju
ne 
Total 
Total 
Patient 
Days 2097 2270 
22
79 
24
96 2185 2452 2902           
1668
1 
Adjust
ed 
Patient 
Days 4790 5130 
49
95 
54
45 4877 
5268 
5824           
3106
1 
  
Colon 
Proced
ures 4 0 4 7 4 5 6 0 0 0 0 0 30 
Other 
GI 
Proced
ures 14 10 22 16 12 18 17 0 0 0 0 0 109 
C-Sec 
Proced
ures 0 0 0 0 0 0 0 0 0 0 0 0 0 
Hyst-
Abd 
Proced
ures 5 5 4 8 7 6 8 0 0 0 0 0 43 
Hyst-
Vag 
Proced
ures 0 0 0 0 0 0 0 0 0 0 0 0 0 
Joint-
Hip 
Proced
ures 31 15 32 28 23 29 12 0 0 0 0 0 170 
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Joint-
Knee 
Proced
ures 19 24 20 25 33 30 24 0 0 0 0 0 175 
Other 
Ortho
pedic 
Proced
ures 6 15 18 11 7 12 22 0 0 0 0 0 91 
Other 
Proced
ures 96 90 
11
7 
10
8 84 92 94 0 0 0 0 0 681 
 
 
 
 
 
 
 
                        
  
Significant Organism Average Costs per Infection 
MRSA 
$27,
083   
SSI  
$20,
785                         
Overall Surgical Site Infections  
Infecti
on 
Type 
July Aug Se
pt 
Oc
t 
Nov Dec Jan Feb Mar Ap
ril 
M
ay 
Ju
ne 
Total  
Superf
icial 
incisio
nal 
Primar
y (SIP) 
3 0 0 0 1 1 0 0 1 0 0 0 6  
Superf
icial 
Incisio
nal 
Second
ary 
(SIS) 
0 0 0 0 0 0 0 0 0 0 0 0 0  
Deep 
Incisio
nal 
Primar
y 
(DIP) 
0 0 0 0 0 2 1 1 0 0 0 0 4  
Deep 
Incisio
nal 
Second
ary 
(DIS) 
0 0 0 0 0 0 0 0 0 0 0 0 0  
Organ 
Space 
0 1 0 0 0 0 0 0 1 0 0 0 2  
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SSI 
Total 
3 1 0 0 1 3 1 1 2 0 0 0 12  
Date of 
SSI & 
Type 
   
List Surgical Site Infection specifics in monthly overview section  
    
      
  
      
  
         
Hospital-Acquired Organisms Overall  
MRSA 0 0 0 0 1 1 0 0 0 0 0 0 2  
STAU 1 0 0 0 0 1 1 1 0 0 0 0 4  
STRE
P 
0 0 0 0 0 0 0 0 0 0 0 0 0  
ENTC 0 1 0 0 0 0 0 0 0 0 0 0 1  
PSAE 0 0 0 0 0 1 0 0 0 0 0 0 1  
CNST 0 0 0 0 0 0 0 0 0 0 0 0 0  
Candi
da 
1 0 0 0 0 0 0 0 0 0 0 0 1  
ENTB 1 0 0 0 0 0 0 0 0 0 0 0 1 
Other 0 2 0 0 0 1 0 0 2 0 0 0 5 
Total 3 3 0 0 1 4 1 1 2 0 0 0 15 
    
      
  
      
  
        
Estimated HAI Cost for Select Infections 
Overal
l 
July Aug Se
pt 
Oc
t 
Nov Dec Jan Feb Mar Ap
ril 
M
ay 
Ju
ne 
TOT
AL 
MRSA 
Cost 
$0 $0 $0 $0 $27,
083 
$27,
083 
$0 $0 $0 $0 $0 $0 $54,1
66 
SSI 
Cost 
$62,
355 
$20,
785 
$0 $0 $20,
785 
$62,
355 
$20,
785 
$20,
785 
$41,
570 
$0 $0 $0 $249,
420 
Total $62,
355  
$20,
785  
$0  $0  $47,
868  
$89,
438  
$20,
785  
$20,
785  
$41,
570  
$0  $0  $0  $303,
586 
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Appendix B  
Significant Organism Average Costs per Infection: 
• SSI- $20,785 
Estimated average number of surgical procedures performed per year: 
• 1300 
Overall Surgical Site Infections for Fiscal year 2015: 
• 12 
Estimated HAI Cost for Select Infections for Fiscal year 2015: 
• $249,420 
SAGE CHG wipes 
• $5.85/pack with 2 packs per patient. 
• $11.70 per patient for preoperative bathing 
Cost of SAGE 2% CHG Cloth Annually 
• $12,168.00 
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Appendix C 
SWOT Analysis 
Through the analysis of the materials that I have created for this course several issues 
have been discovered.  
Strengths of my project include the support of the Perioperative Leadership Team, and 
Physician champion.  
Weaknesses include a lack of standardized methods of care in relation to SSI prevention, 
and adherence to SCIP infection process measures.  
Opportunities for improvement include surveillance to improve situational awareness, 
and performance improvement in reporting surgical site infections to key stakeholders. 
Threats to my project are difficulty in obtaining surgeons’ agreement to participate (there 
is already some push back from certain surgeons), difficulty in screening and 
decolonizing patients who have bypassed the usual preadmission process (patients in the 
ER, weekends and holidays), and time constraints (documenting and auditing).  
 
PREVENTING SURGICAL SITE INFECTIONS BY UTILIZING CHG  
 
25
 
 
 
 
 
 
 
 
Appendix D 
 
 
 
 
 
 
SSI 
Patient Factors 
Preoperative Factors Organizational 
Factors 
Surgical Site Infection Diagram  
Cost of 
Materials 
Poor 
leadership 
 
Poor hand 
hygiene 
Lack of or no 
preoperative 
bathing 
Patient 
body 
colonizatio
n 
Current infection 
Obese 
Smoking 
Poor 
interdiscipli
nary 
communica
tion 
Perioperative Factors 
Unsterile/ 
contaminated items 
Inadequate surgical 
prophylaxis 
Improper hand 
Hygiene, and 
Surgical attire 
Lack of support  
for implementation 
Patient body 
Colonization 
Surgeon 
Poor surgical 
technique 
Surgical Site not 
effectively cleaned 
Antibiotics not given 
Per SCIP protocol 
Improper  
Wound care 
Shaving 
at home 
Unwilling to make 
practice changes 
Postponing 
elective surgery if 
remote infection is  
known 
Health Care Delivery 
Avoidance of  
Intraoperative 
hypothermia 
Inadequate 
Staffing in all 
Phases of care 
Post operative 
wound  
contamination 
Antibiotics not 
Discontinued within 
24 hr. period 
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Appendix E 
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Task	# Task	Description Responsible	(Who) To	be	Completed	by	
(When)
Status Comments
OUTPATIENT	FOCUS
1 Administrative
1A Conduct	Kick-off/	Planning	Meeting Periop	leader,	CNS,	
Infection	control	
3/25/15 Complete
1B Draft	charter Periop	leader 3/25/15 Complete
1C Review/approve	project	charter Periop	leader,	CNS,	
Infection	control	
5/5/15 In	process
1D Update	associated	policies CNS,	CNL,	Periop 5/4/15 In	process
1E Update	associated	order	sets CNS/Periop/CNL 5/8/15 In	process Forms	to	create/submit	requested	order	set	have	been	
received	and	will	be	completed/submitted.		Actual	duration	
for	request	to	be	approved	is	unknown	at	this	time.
1F Determine	which	product	will	be	used/supplied CNS/Periop 4/24/15 Complete Sage	brand;	$11/3	pack	with	2	packs	per	patient	=	$22	per	
patient
1G Determine	how	product	will	be	paid	for	i.e.,	periop?		FHS?		 Periop	leader/ 5/8/15 In	process
1H Determine	how	product	will	be	distributed Periop	leader Not	started How	will	product	be	delivered	to	FMG	and	how	will	it	be	
ordered
1I Draft	Standardized	Process	to	be	used	within	PATs	regionally CNS/CNL 5/8/15 In	process
1J Finalize	Standard	Process	to	be	used	with	PATs	regionally CNL/CNS 5/12/15 Not	started
1K Draft	sustainability	plan Periop	leader,	CNS,	
CNL,	Infection	control	
Not	started
1L Establish	baseline	data Periop	leader 2/5/15 Complete
2 Communication	and	Training
2A Communicate	standard	process	to	periop	leadership:	wipes CNS/CNL 5/20/15 Complete Next	PLC	Meeting	is	scheduled	for	5/20	@	SCH;	Next	Clin	
Ops	meeting	(Directors)	is	scheduled	for	5/19
2B Develop	education	for	physicians:		wipes CNS/CNL In	process Scrub	News?
2C Develop	education	for	staff:		wipes CNS/CNL In	process Bugbyte
2D Develop	patient	education CNL/CNS In	process
2E Develop	communication	plan Periop	leader,	CNS,	
Infection	control,	CNL
4/28/15 Complete Living	document,	will	continue	to	be	updated	as	needed
2F Identify	how	progress	will	be	communicated	i.e.,	dashboard Periop	
leader/CNS/CNL
6/8/15 Complete
2G Determine	how	project	will	be	evaluated	post-implementation CNL/CNS 6/12/15 Complete
2H Send	video	links	to	team	for	review	and	discussion CNS/CNL 5/4/15 Complete
2I Provide	current	information	that	can	be	used	for	Bugbyte,	etc. CNS/CNL 5/4/15 Complete
3 Implementation
3A Target	implementation	date:		OUTPATIENT Team 9/1/15 Not	started
INPATIENT	FOCUS
4 Administrative
4A Update	associated	policies CNS/CNL In	process Not	started
4B Determine	product	availability	and	distribution Periop	leader Not	started Based	on	work	associated	with	Phase	I	OUTPATIENT
4C Establish	baseline	data Periop	leader 3/25/15 Complete
5 Communication	and	Training
5A Develop	education	for	physicians:		wipes CNS/CNL Not	started
5B Develop	education	for	staff:		wipes CNS/CNL Not	started
5C Develop	patient	education CNS/CNL Not	started
5D Update	communication	plan Periop	leader,	CNS,	
Infection	control,	CNL
Not	started
5E Identify	how	progress	will	be	communicated	i.e.,	dashboard Periop	
leader/CNS/CNL
Not	started
5F Determine	how	project	will	be	evaluated	post-implementation Periop	
leader/CNS/CNL
Not	started
6 Implementation
6A Target	implementation	date:		INPATIENT Team 12/1/15 Not	started
7 Administrative
7A Update	associated	policies CNS/CNL Not	started
7B Establish	baseline	data Periop	leader Not	started
8 Communication	and	Training
8A Develop	education	for	periop	leadership:	clipping,	attire CNS/CNL Not	started
8B Develop	education	for	physicians:		clipping,	attire CNS/CNL Not	started
8C Develop	education	for	staff:		clipping,	attire CNS/CNL Not	started
8D Update	communication	plan CNS/CNL Not	started
8E Identify	how	progress	will	be	communicated	i.e.,	dashboard Periop	
leader/CNS/CNL
Not	started
8F Determine	how	project	will	be	evaluated	post-implementation Periop	
leader/CNS/CNL
Not	started
8G Patient	education Periop	
leader/CNS/CNL
Not	started
9 Implementation
9A Target	implementation	date:		Attire	and	Hair	Clipping Team 12/1/15 Not	started
CHI	Franciscan	SSI	Bundle	Implementation	Project	(Last	updated	5/4/2015)
PHASE	I:		CHG	Wipes
PHASE	II:		Attire	and	Hair	Clipping
